Status:
UNKNOWN
Endometrial Markers in Autoimmune Diseases
Lead Sponsor:
Odense University Hospital
Conditions:
Endometrial Receptivity
Fertility
Eligibility:
FEMALE
18-45 years
Brief Summary
Autoimmune diseases cause a decreased endometrial receptivity during the implantation window, most likely changing the endometrial cytokines pattern due to dysregulation of the inflammatory processes....
Eligibility Criteria
Inclusion
- Study group:
- \* Females with infertility combined with autoimmune disease and in fertility treatment.
- Control group:
- \* Female from couples with severe male infertility and in fertility treatment.
Exclusion
- Language problems to such an extent that the subjects do not understand the scope of the study.
- Abnormal follicle stimulating hormone (FSH),
- Abnormal antral follicles Count
- Genital infections
- Endometriosis
- Tubal occlusion
- Polycystic ovarian syndrome
Key Trial Info
Start Date :
February 18 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT03843034
Start Date
February 18 2019
End Date
December 31 2023
Last Update
November 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre of Andrology & Fertility Clinic, Department D, Odense University Hospital
Odense, Denmark, DK-5000